Figures & data
Figure 2 Geographic distribution of adult severe asthma patients with high oral corticosteroid exposure enrolled in ISAR according to biologic initiation status. ISAR: International Severe Asthma Registry. Data are presented as % not initiated/% initiated. Green: approximately equal proportion of biologic non-initiators to initiators; Blue: More likely not to initiate biologics; Yellow: more likely to initiate biologics.
![Figure 2 Geographic distribution of adult severe asthma patients with high oral corticosteroid exposure enrolled in ISAR according to biologic initiation status. ISAR: International Severe Asthma Registry. Data are presented as % not initiated/% initiated. Green: approximately equal proportion of biologic non-initiators to initiators; Blue: More likely not to initiate biologics; Yellow: more likely to initiate biologics.](/cms/asset/911cbeee-90ff-486d-ac05-933724ff3ec7/djaa_a_12151623_f0002_c.jpg)
Table 1 Baseline Demographic Characteristics for ISAR Patients with Severe Asthma and High Oral Corticosteroid Exposure Who Were and Were Not Initiated on Biologic (Bx) Therapy
Table 2 Baseline Clinical Characteristics for ISAR Patients with Severe Asthma and High Oral Corticosteroid Exposure Who Were and Were Not Initiated on Biologic (Bx) Therapy
Figure 3 Clinical characteristics of adult severe asthma patients with high oral corticosteroid exposure enrolled in ISAR who did and did not initiate biologic therapy.
![Figure 3 Clinical characteristics of adult severe asthma patients with high oral corticosteroid exposure enrolled in ISAR who did and did not initiate biologic therapy.](/cms/asset/02a325c2-bfbc-4a4d-a882-bae4cf20bf5c/djaa_a_12151623_f0003_c.jpg)